Advisory Services Network’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
ISL
PA
Advisory Services Network's CORT Position: Q2 2026 in Review
Advisory Services Network sold out of Corcept Therapeutics (CORT) in Q2 2026, closing a stake of 739 shares — an estimated $29.8K sold.
Advisory Services Network first reported a position in CORT in Q1 2018 and held it in 17 quarters. The position peaked at $803K in Q1 2025. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.
- Advisory Services Network reported no remaining Corcept Therapeutics position as of Q2 2026 after selling out during the quarter.
- Advisory Services Network sold 739 Corcept Therapeutics shares in Q2 2026, an estimated $29.8K.
- Advisory Services Network first reported a position in Corcept Therapeutics in Q1 2018 and held it in 17 quarters.
- Advisory Services Network's Corcept Therapeutics position peaked at $803K in Q1 2025.
- 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.
Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.